Our Products & Pipeline
Breakthrough Therapies: The Currax Difference
At the heart of Currax’s mission are medicines created to transform patients’ lives. Our pipeline is filled with solutions developed to deliver sustainable, measurable results—helping each patient reclaim their health and rewrite their story. We start with the understanding that clinicians treat individuals, not just diseases, and that every patient is unique.
Through comprehensive research, we explore the full potential of our medications, providing clinicians with the critical information they need to help as many patients as possible.
| Marketed Products | Phase 1 | Phase 2 | Phase 3 | Marketed | Phase 4 |
|---|---|---|---|---|---|
| CONTRAVE® (naltrexone HCI/bupropion HCI) Obesity | |||||
| INFORMUS Clinical Trial NCT06098079 Cardiovascular Outcomes (Interventional) | |||||
| ONZETRA® Xsail® (sumatriptan nasal powder) Migraine | |||||
| SILENOR® (doxepin) Sleep | |||||
| TREXIMET® (sumatriptan/naproxen sodium) Migraine | |||||
| Pipeline | |||||
| CR-101-1 Obesity Once-a-day | |||||
| CR-101-2 Obesity Once-a-day | |||||
| CT-101 Obesity Combination | |||||
| CM-101 Obesity Maintenance | |||||
| CX-101 Use Disorder Weight Gain | |||||
| QDC-101 Obesity Combination | |||||
Marketed Products
- CONTRAVE® (naltrexone HCI/bupropion HCI) Obesity
- INFORMUS Clinical Trial NCT06098079 Cardiovascular Outcomes (Interventional)
- ONZETRA® Xsail® (sumatriptan nasal powder) Migraine
- SILENOR® (doxepin) Sleep
- TREXIMET® (sumatriptan/naproxen sodium) Migraine
Pipeline
- CR-101-1 Obesity Once-a-day
- CR-101-2 Obesity Once-a-day
- CT-101 Obesity Combination
- CM-101 Obesity Maintenance
- CX-101 Use Disorder Weight Gain
- QDC-101 Obesity Combination
Generic Products
For a complete list of the generic medications distributed by Currax and its affiliates, please contact Customer Service:
Phone: 1-800-793-2145
Fax: 1-862-260-8752
[email protected]
Independent Research & Educational Grants
Currax is committed to the advancement of healthcare and improving patient outcomes through the support of investigator-initiated research (IIR) and independent educational programs and activities. We actively support and collaborate on initiatives designed to advance medical and scientific knowledge about our products and therapeutic areas of interest. View eligibility requirements and learn how to apply for support.